In breast cancer, locked nucleic acid (LNA)‐i‐miR‐221 inhibits miR‐221‐mediated NF‐κB activation to reduce the secretion of tumor‐promoting cytokines of CAFs.405. This evidence concerns the gene NFKB1 and breast carcinoma.